![Eisai Alzheimer Drug Shows Promise in Injected-At-Home Form](/i/c/f9af64f3-4c3e-ec40-7425-aa877e697281.webp)
Eisai Alzheimer Drug Shows Promise in Injected-At-Home Form
An experimental version of Eisai Co.’s Alzheimer’s drug that might be given in patients’ homes exceeded the power
2023-10-26 08:28
![Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker](/i/c/57db7df8-52e3-4727-d95e-be3b0e875787.webp)
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:17
![Eisai’s Alzheimer’s Drug Wins Approval in Japan, Following US](/i/c/bfaa0415-61ea-ea09-56de-a416b7d8c546.webp)
Eisai’s Alzheimer’s Drug Wins Approval in Japan, Following US
Eisai Co.’s breakthrough Alzheimer’s disease drug won clearance from Japanese regulators after the medicine was fully cleared in
2023-09-25 14:26
![Eisai Azheimer’s Drug Set to Win Japanese Approval, Following US](/i/c/26309d98-4c2b-6630-c3a2-e92070b77028.webp)
Eisai Azheimer’s Drug Set to Win Japanese Approval, Following US
Eisai Co.’s breakthrough Alzheimer’s disease drug is poised to gain the backing of Japanese regulators after the medicine
2023-08-21 21:28
![China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US](/i/c/7dd881b5-6401-77a1-4e38-dee82004c039.webp)
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:29
![Medicare Proposes Expanding Patient Access to Alzheimer’s Scans](/i/c/c6cbeab9-c47e-db61-7ab9-036e842008ff.webp)
Medicare Proposes Expanding Patient Access to Alzheimer’s Scans
The US Medicare program will roll back rules that limited coverage for an expensive imaging scan for people
2023-07-18 06:25
![Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success](/i/c/8af79b5e-72ef-4fc9-41b3-a8f93180bb24.webp)
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
2023-07-17 22:51
![Eisai Appoints CEO’s 34-Year-Old Son to Lead Global Alzheimer Drug Program](/i/c/b89b1958-8e9f-41e5-34b7-296018d1a252.webp)
Eisai Appoints CEO’s 34-Year-Old Son to Lead Global Alzheimer Drug Program
Japanese drug giant Eisai Co. said global Alzheimer drug program officer Ivan Cheung will retire at the end
2023-07-11 09:56
![How a Japanese Drugmaker Clinched Win Over Alzheimer’s](/i/c/80e9deea-628a-537f-7104-e8d946fcf056.webp)
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46
![Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy](/i/c/30b3df02-1e66-d166-e883-03a05eed03e8.webp)
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:16
![Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug](/i/c/0feb1972-25cd-5746-416f-d99646ea34eb.webp)
Eisai, Biogen Clinch FDA Advisers’ Support for Alzheimer’s Drug
Eisai Co.’s Alzheimer’s disease drug developed with Biogen Inc. gained support from advisers to US regulators, paving the
2023-06-12 09:28
![AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs](/i/c/2fd308ee-6d01-21e8-8bcd-ce585c5fd1de.webp)
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker
2023-06-07 05:28